XML 35 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statement of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:    
Net (loss) income $ (10,456,870) $ 6,644,465
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Acquired in-process research and development 3,087,832 0
Fair value of warrants for services provided 371,895 0
Share-based compensation expense 511,079 219,245
Non-cash interest expense 46,315 661,224
Change in fair value of convertible promissory notes (9,317) (9,877,857)
Gain on extinguishment of debt (125,577) 0
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (1,611,492) 4,332
Accounts payable (866,007) 556,270
Accrued expenses and other current liabilities 252,655 757,701
Cash used in operating activities (8,799,487) (1,034,620)
Cash flows from investing activities:    
Acquired in-process research and development (250,000) 0
Cash used in investing activities (250,000) 0
Cash flows from financing activities:    
Proceeds from the issuance of convertible bridge notes 0 25,000
Proceeds from the issuance of note payable 0 124,054
Proceeds from the sale of common stock in initial public offering, net 24,428,626 0
Proceeds from the sale of common stock in private placement, net 28,982,575 0
Cash provided by financing activities 58,394,036 1,149,054
Net increase in cash, cash equivalents and restricted cash 49,344,549 114,434
Cash and cash equivalents at beginning of period 341,037 226,603
Cash and cash equivalents at end of period 49,685,586 341,037
Supplemental disclosure of non-cash financing activities:    
Issuance of warrants in conjunction with Series A preferred stock and placement agent fees 309,390 78,967
Issuance of warrants in conjunction with Series A preferred stock and placement agent fees 2,837,832 0
Unpaid offering costs in accounts payable 102,071 117,631
Change in fair value of redeemable common stock to redemption value 53,330 97,000
Conversion of preferred stock and redeemable common stock upon initial public offering 21,064,623 0
Demand Notes to Convertible Promissory Notes    
Supplemental disclosure of non-cash financing activities:    
Conversion of convertible promissory notes 5,866,290 0
Bridge Notes to Series A Preferred Stock    
Supplemental disclosure of non-cash financing activities:    
Conversion of convertible promissory notes 0 529,902
Convertible Promissory Notes To Series Seed Preferred Stock    
Supplemental disclosure of non-cash financing activities:    
Conversion of convertible promissory notes 0 6,291,288
Series Seed Preferred Stock    
Cash flows from financing activities:    
Proceeds from the sale of preferred stock 4,982,835 950,000
Series A Preferred Stock    
Cash flows from financing activities:    
Proceeds from the sale of preferred stock $ 0 $ 50,000